We've discussed the speakers at Thursday/Friday's Part 15 hearing on social media -- and now we know who will be doing the listening (and questioning) from the FDA side:
- Thomas W. Abrams - Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) - Center for Drug Evaluation, and Research (CDER)
- Kathryn J. Aikin - Social Science Analyst, DDMAC - CDER
- Rachel E. Behrman - Deputy Director, Office of Medical Policy (OMP) - CDER
- Gerald Dal Pan - Director, Office of Surveillance and Epidemiology - CDER
- Kristin Davis - Deputy Director, DDMAC - CDER
- David J. Horowitz - Assistant Commissioner for Policy, Office of Policy, Planning, and Budget - Office of the Commissioner
- Ele Ibarra-Pratt - Branch Chief, Advertising and Promotional Labeling Branch - Center for Biologics Evaluation Research
- Jean-Ah Kang - Special Assistant to the Director, DDMAC - CDER
- Sharon Kapsch - Chief, MDR Policy Branch - Center for Devices and Radiological Health (CDRH)
- Dorothy R. McAdams - Supervisory Veterinary Medical Officer, Division of Surveillance - Center for Veterinary Medicine
- Seth S. Ray - Associate Deputy Chief Counsel for Drugs and Biologics - Office of the Chief Counsel
- Robert Temple - Director, OMP - CDER
- Deborah Wolf - Regulatory Counsel, Office of Compliance - CDRH
